Depo Provera (Medroxyprogesterone) Drug Information: Overdosage and Contraindications

May 27, 2012

Osteoporosis is a condition of increased susceptibility to fracture due to fragile bone.
Osteoporosis weakens bone and increases risk of bone fracture.
Bone mass (bone density) decreases after 35 years of age and decreases more rapidly in women after menopause.
Key risk factors for osteoporosis include genetics, lack of exercise, lack of calcium and vitamin D, personal history of fracture as an adult, cigarette smoking, excessive alcohol consumption, history of rheumatoid arthritis, low body weight, and family history of osteoporosis.
Patients with osteoporosis have no symptoms until bone fractures occur.
The diagnosis of osteoporosis can be suggested by X-rays and confirmed by tests to measure bone density.
Treatments for osteoporosis, in addition to prescription osteoporosis medications, include stopping use of alcohol and cigarettes, and assur...

Depo Provera

font size

No information provided.

The use of Depo-Provera CI is contraindicated in the following conditions:

Known or suspected pregnancy or as a diagnostic test for pregnancy.
Active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease [see WARNINGS AND PRECAUTIONS].
Known or suspected malignancy of breast [see WARNINGS AND PRECAUTIONS].
Known hypersensitivity to Depo-Provera CI (medroxyprogesterone acetate) or any of its other ingredients [see WARNINGS AND PRECAUTIONS].
Significant liver disease [see WARNINGS AND PRECAUTIONS].
Undiagnosed vaginal bleeding [see WARNINGS AND PRECAUTIONS].